374Water Q2 Revenue Surges 280% on OC San Milestone
Read source articleWhat happened
374Water reported Q2 2026 revenue of $2.26 million, up 280% from $0.6 million in Q2 2025, driven by completion of the Orange County Sanitation District Factory Acceptance Test and associated revenues. This suggests the OC San contract, which previously caused a ~$1.9 million revenue reversal and a $1.6 million loss provision, has now cleared a critical technical hurdle and resumed revenue recognition. However, the release provides no detail on cash flow, operating expenses, or the Orlando Waste Destruction Services hub, which remain central concerns given the company's end-2025 cash of $3.2 million and going concern warning. The revenue jump, while impressive relative to a tiny base, still represents only about one-third of the company's guided FY2026 revenue range of $6M–$8M, and it is uncertain whether the company can achieve profitability or reduce dilution. Investors should await the full 10-Q filing to assess whether cash burn has moderated and whether Orlando has begun generating recurring third-party volumes before upgrading the thesis.
Implication
The successful OC San factory acceptance test should reduce contract accounting volatility and potentially unlock milestone payments, improving near-term liquidity if collected. Yet, investors must verify whether the revenue recognized is cash-backed or subject to further collectability risk, and whether the contract's remaining scope is profitable after the previous loss provision. The Orlando hub remains unproven, and without disclosed multi-month third-party waste volumes, the central WDS thesis is still unvalidated. Given the company's $3.2 million cash balance at end-2025 and limited S-3 capacity, the news alone does not eliminate the risk of dilutive financing. Thus, while the operational progress is encouraging, the stock likely still trades on financing capacity and future Orlando data rather than durable cash flow, warranting continued caution.
Thesis delta
The OC San factory acceptance test passed, removing a key execution risk that had caused a revenue reversal and loss provision; this shifts the base case from contract failure to potential recovery of equipment revenue. However, the thesis still hinges on Orlando's conversion to recurring WDS and on cash collection, neither of which is addressed in this release. Consequently, the overall WAIT stance is maintained but with reduced downside from the OC San contract.
Confidence
Medium